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Background: China pledged to join the global effort to eliminate measles by 2012. To improve measles control
strategy, the epidemic trend and population immunity of measles were investigated in 1951–2011 in Beijing.
Methods: The changing trend of measles since 1951 was described based on measles surveillance data from
Beijing Centre of Disease Control and Prevention (CDC). The measles vaccination coverage and antibody level were
assessed by routinely reported measles vaccination data and twenty-one sero-epidemiological surveys.
Results: The incidence of measles has decreased significantly from 593.5/100,000 in 1951 (peaked at 2721.0/100,000
in 1955), to 0.5/100,000 in 2011 due to increasing vaccination coverage of 95%-99%. Incidence rebounded from 6.6/
100,000 to 24.5/100,000 since 2005 and decreased after measles vaccine (MV) supplementary immunization
activities (SIAs) in 2010. Measles antibody positive rate was 85%-95% in most of years since 1981. High-risk districts
were spotted in Chaoyang, Fengtai and Changping districts in recent 15 years. Age-specific incidence and
proportion of measles varied over time. The most affected population were younger children of 1–4 years before
1978, older children of 5–14 years in 1978–1996, infant of <1 years and adults of ≥15 years in period of aim to
measles elimination.
Conclusion: Strategies at different stages had a prevailing effect on the epidemic dynamics of measles in recent 60
years in Beijing. It will be essential to validate reported vaccination coverage, improve vaccination coverage in
adults and strengthen measles surveillance in the anticipated elimination campaign for measles.
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Measles is a severe respiratory infectious disease caused by
measles virus [1]. Measles has been statutorily notifiable
since the earlier National Notifiable Diseases Reporting
System (NNDRS) was established in 1950. Hospitals
reported cases by posting a card to the county Center for
Disease Control (CDC). Every month county CDC aggre-
gated data that were then submitted through prefecture
and provincial CDC to reach the national level [2]. In 1987
NNDRS was further improved, which reported basic epide-
miologic data including age, sex, date of disease onset and
residence by electronic document each month [3]. Since
2004 after severe acute respiratory syndrome (SARS),
NNDRS was upgraded to direct reporting through network
to improve timeliness, completeness of case reporting [4].* Correspondence: wj81732@yahoo.com.cn
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reproduction in any medium, provided the orFor each suspected case, the local CDC is required to carry
out an epidemiological investigation, including obtaining
specimens for laboratory confirmation since 2000.
Liquid measles vaccine (MV) was introduced in China
in 1965. The 1978 establishment of the national Expanded
Program on Immunization (EPI) resulted in a standard
routine immunization schedule including MV adminis-
tered as 1 dose to infants aged 8 months. In 1986, a 2-
dose schedule using lyophilized MV at 8 months and 7
years of age was implemented [5]. The next step was a
1997 national plan of action for accelerated measles con-
trol that called for 90% MV coverage, measles surveillance
and catch-up campaigns for provinces. In 2005, the World
Health Organization’s (WHO) Regional Committee for
the Western Pacific Region set a target date of 2012 for
measles elimination in the region including China [6,7].
Since 2005, the age of administration of the second dose
was lowered from 7 years to 1.5 years. The 2006–2012his is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hensive measures including 95% MV coverage of 2 doses,
measles surveillance, regional and national supplementary
immunization activities (SIAs), vaccination certificate of
children at admission to child care setting and school
[8,9]. China is a developing country with vast territory of
9.6 million square kilometers and large population of 1.37
billion, which has 23 provinces, 4 municipalities, 5 au-
tonomous regions and 2 special administrative regions
with different levels of economic and social development,
predicting different challenges in reaching measles elimin-
ation. Hence, strategies of prevention and control measles
were slightly different among different provinces.
Beijing is capital of China with a total area of 16,808
square kilometers. According to the 2010 national cen-
sus, there were 19.6 million populations, of which 7 mil-
lion migrants seek work in Beijing out of their province
of origin. Referring to the historical periods of control of
measles in China, combined with different strategies in
Beijing, the strategies evolved from 1951 to 2011 in five
stages (Figure 1):
Stage 1: Period prior to vaccination (1951–1965):
Incidence of measles was in a natural infection state.
Stage 2: Initial period of measles immunization (1966–
1977): MV was administered as 1 dose to infants
aged 6 months. The second and third doses were
administered to children of 4 and 8 years old in
1972. The age of administration of the first dose was
increased to 8 months in 1974. Vaccine cold chain
was not established. No refrigerant equipment was
available and vaccine could not be stored at proper
temperatures. In order to ensure vaccine
immunogenicity, children with a certain age were






























































Figure 1 Measles vaccine immunization program of Beijing and China, 1Stage 3: Period of planned immunization (1978–1996):
The 1978 establishment of the Beijing EPI resulted
in a standard routine immunization schedule as a 2-
dose schedule at 8 months and 1.5 years of age.
Since 1982, Jing55 MV strains were replaced by
Hu191 strains to improve vaccine immunogenicity.
MV immunization population was expanded to
students in Grade 1 and 7 in school, freshman in
college. In 1987, the change of MV dosage form
from liquid to lyophilized improved vaccine stability.
With the gradually improvement of vaccine cold
chain, children could be vaccinated in the whole
year with the establishment of medical institutions
designated inoculation. The subsequent expansion of
cold chain infrastructure allowed routine
immunization to cover the entire country.
Stage 4: Accelerated period of measles control (1997–
2004): Since 2000, SIAs among migrant children
under 7 years old was implemented every year.
Measles vaccination dose was increased from 0.2 ml
to 0.5 ml to enhance vaccine immunogenicity in
2004.
Stage 5: Period of aim to measles elimination (2005–
2011): Since 2005, the vaccination schedule was
recommended 3-doses vaccine schedule at 8
months, 1.5 and 6 years of age with univalent MV
in all districts. Measles, rubella and mumps
combined attenuated live vaccine (MMR) and
measles and rubella combined attenuated live
vaccine (MR) were introduced into the
immunization program in 2006 and 2009,
respectively. Measles vaccination campaign targeted
migrant workers aged 15–40 years was
implemented every year. The synchronized
nationwide SIAs targeting children aged 8 months
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http://www.biomedcentral.com/1471-2458/13/986Global vaccination programs have led to a worldwide
decrease in the occurrence of measles [10,11], with some
areas documenting an interruption of transmission of
the endemic virus [12,13]. This study aimed to review
the changing epidemiology of measles, measles vaccin-
ation coverage in relationship to the trend of measles inci-
dence, herd immunity of the population against measles
through periodic sero-epidemiological surveys from 1951
to 2011 in Beijing.
Methods
Case definition and source of data
Data of measles cases and deaths in 1951–2011 were
obtained from Beijing CDC. Suspected measles cases was
diagnosed clinically as a person of any age with fever, rash
and one of the following: cough, coryza or conjunctivitis,
classified as either laboratory-confirmed, epidemiologically
linked, clinically confirmed or discarded, by guidelines of
World Health Organization [14,15]. With the improve-
ment of surveillance and moving towards measles elimin-
ation, the demands of measles case classification have
changed during different phases. Before period of planned
vaccination in 1978, almost all measles were clinical diag-
nosed case due to lack of routine and convenient labora-
tory test method. Since 1980, laboratory test method of
measles antibody was used in case diagnosis. The national
serological surveillance laboratory network was established
in 2001 to provide serological confirmation of measles in-
fection and to support measles surveillance. All cases in-
cluded in this analysis were confirmed cases including
laboratory or clinical confirmed and epidemiological re-
lated cases. Annual incidence and morbidity (per 100,000
populations) were calculated based on Beijing census data
reported by the statistical yearbook of Beijing.
Vaccination coverage
Administrative data based on report from health centre
staff were the main sources of immunization coverage.
The doses of vaccines administered in a given period (usu-
ally 1 month) were reported to prefecture CDC, in which
data were collected and reported to Beijing CDC. In
Beijing CDC, data were aggregated to estimate the average
coverage rate using the numerator (the total number of
actually immunized children) divided by the denominator
(the total number of children who should be immunized
by immunization schedule). For example, the 1978 estab-
lishment of the Beijing Expanded Program Immunization
(EPI) recommended a standard routine immunization
schedule as a 2-dose MV at age of 8 months and 1.5 years.
The target population of coverage rate of first and second
doses was children aged more than 9 and 19 months old,
respectively, who lived in Beijing for more than 2 months.
Vaccine immunization data from 1971 to 2011 were
obtained from Beijing CDC.Sero-epidemiological surveys
In order to assess the level of immunity of the population
against measles, sero-epidemiological surveys were
conducted in 1973–1977, 1979-1982, 1986, 1989, 1990,
1995-2000, 2002, 2003, and 2007 in selected districts of
Beijing. The sampling procedure was based on a three-
stage protocol. Firstly, at least 3 prefectures were selected
as random or specific survey sites from downtown, subur-
ban and rural areas. Secondly, the villages were sampled by
probability-proportional-to-size sampling (PPS). Thirdly, a
number of objects per birth cohort were selected by con-
venience sampling method in the local population. Blood
samples were collected from healthy persons with consent.
Information integrated by the time of blood collection in-
cluding basic demographic data, history of previous measles
infection and MV vaccination. The blood samples were an-
alyzed for measles IgG antibodies using measles enzyme
immunoassay. Measles sero-epidemiology data from
1973 to 2007 were obtained from Beijing CDC. Sero-
epidemiology surveys were performed with the approval
of Beijing CDC ethics committee.
Statistical analyses
We analyzed the data of confirmed measles cases reported
in Beijing in 1951–2011 to identify epidemiological chan-
ging features, spatial geographic and age distribution, vac-
cination coverage and measles antibody positive rate. We
used Microsoft Excel 2000, SPSS 17.0 and Mapinfo 8.5 for
data analysis.
Results
Incidence and mortality of measles in Beijing
Overall, 1,507,956 reported cases and 11,130 deaths of
measles were recorded in Beijing over the 60-year
period. Figure 2 showed the temporal pattern of the
incidence and mortality of measles in Beijing in 1951–
2011. The overall declining trend was clear, with the an-
nual average incidence decreasing from 593.5/100,000 in
1951 to 0.5/100,000 in 2011 and mortality declining
from 48.4/100,000 in 1951 to 0 in 2011. From 1951 to
1965, measles incidence fluctuation ranged from 390.7/
100,000 to 2721.0/100,000. A frequent peak of incidence
was observed every 2–3 years. Measles mortality was
high, ranging from 2.5/100,000 to 48.4/100,000. In
1966–1977, incidence ranged from 32.2/100,000 to
397.1/100.000, which declined 92.7% compared with
incidence before vaccination. There was a 3–4 year peri-
odic recurrent pattern. Mortality declined significantly
to 0.1-1.5/100,000. In 1978–1996, there were two phases
in variation of incidence. Before 1985, average incidence
was 78.7/100,000. Since 1986, the incidence of measles
has remained at a relatively low level, less than 2.0/
100,000 in most of years. No measles deaths were
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Figure 2 Measles incidence and morbidity in Beijing, 1951–2011.
Li et al. BMC Public Health 2013, 13:986 Page 4 of 11
http://www.biomedcentral.com/1471-2458/13/986was between 0.7/100,000 and 6.6/100,000. In 2005–
2011, incidence rebounded from 6.6/100,000 to 24.5/
100,000. After MV SIAs in 2010, incidence decreased to
0.5/100,000 in 2011. 4 deaths were reported in 1997–
2011.Figure 3 Age-specific incidence and proportion of measles in Beijing,
1985–1986 and 1997–1999 and the age-specific incidence in 1963–1977, 19Age distribution of measles
Age-specific incidence of measles varied over time. In
1957–1962 prior to vaccination, high measles incidence,
685.5/100,000 to 14,743.2/100,000, was found in chil-
dren aged ≤14 years, especially among children aged 1–21957–2011. The measles cases by age groups in 1963–1972,
85–1986 and 1997–1999 were not recorded in detail.
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introduction of initial planned vaccination in 1978–1984,
incidence decreased dramatically from 237.0/100,000 to
465.3/100,000 in children aged ≤14 years. In 1987–1996,
incidence declined continually in all age groups, ranging
from 0.1/100,000 to 6.4/100,000. Since this period, age-
specific incidence showed a change, three peaks of higher
incidence were found in infants of <1 years, children of
5–7 years and adults of 20–30 years. In 2000–2004, inci-
dence increased in all age groups, ranging from 3.6/
100,000 to 61.5/100,000 for children aged ≤14 years and
1.1/100,000 to 11.9/100,000 for adults aged ≥15 years,
with two crest in infants of <1 years and adults of 20–30
years. In 2005–2010, age-specific incidence increased to
5.1/100,000-82.9/100,.000 for children aged ≤14 years and
2.3/100,000-28.0/100,000 for adults aged ≥15 years, with
highest 373.0/100,000 in infants aged <1 years. After MV
SIA in 2010, incidence declined greatly to 0–1.2/100,000
for ≥2 years age group, while incidence was 29.9/100,000
for <1 years age group and 5.8/100,000 for 1–2 years age
group (Figure 3).
Age-proportion distribution of measles cases varied
over time. From 1957 to 1962, the most affected age
groups were children of 1–4 years old, with proportion
of 91.0%. The proportion of 5–9 years was 7.0%. From
1973 to 1977, the proportion of measles cases decreased
to 59.1% in children of 1–4 years, but increased to 40.7%
in children of 5–9 years. From 1978 to 1984, the propor-
tion of 1–4 years and 5–9 years age groups were con-
tinually decreased to 23.2% and 33.0%, respectively. The
affected age groups expand to 10–14 years age group
with 26.4% and ≥15 years with 12.0%. In 1987–1996, the
proportion of 1–14 years age group decreased to 5.6%-
18.0%, while the proportion of adults of ≥15 years in-
creased to 61.4%. In 2000–2004, proportion for infants
of <1 years and children of 1–4 years increased to 11.8%
and 15.6%, gradually. Adults of ≥15 years accounted for
56.5%. In 2005–2011, proportion of infants aged <1
years continually increased to 23.5%. Adults aged ≥15
years accounted for 52.9% (Figure 3).
Spatial distribution of measles incidence
Measles was observed in all districts in Beijing, while
the spatial distribution varied from 1982 to 2011
(Figure 4). In 1982–1985, measles broke out in all
districts and the incidence range from 38.3/100,000
to 160.2/100,000. In 1986–1996, measles incidence
decreased dramatically in all districts, ranging from
0.2/100,000 to 3.6/100,000. In 1997–2004, incidence
of all districts remained lower level at 0.1/100,000
to 10.5/100,000. In 2005–2010, incidence in all districts
increased slightly from 2.1/100,000 to 27.3/100,000.
The main high risk districts were Chaoyang, Fengtai
and Changping. After MV SIAs in 2010, incidence inall districts declined dramatically to lowest level, which
was 0 in three districts.
Seasonality of measles
Peaks in the reported measles mainly occurred from
March to May in 1985–2010, while it was no clear sea-
sonal trend in 2011 when incidence declined to the low-
est level (Figure 5).
Vaccination coverage of measles vaccine
From 1971 to 1977, the MV coverage rate of first dose
increased from 71.2% to 88.6%, while measles incidence
remained high level during this period. During period of
planned vaccination in 1978–1996, the MV coverage rate
of first and second doses increased gradually from 91.2%
to 99.9%, and measles incidence in entire population de-
creased dramatically from 146.0/100,000 to 0.3/100,000
and incidence in children of 1–14 years also declined
greatly from 616.7/100,00, to 0.1/100,000. During accel-
erated period of measles control from 1997–2004, the
MV coverage rate of second dose appeared a decline
around 88.4% -94.5% in 2002–2004, which was probably
related to rebound of measles incidence of whole popu-
lation and children of 1–14 years in 2005 (Figure 6).
Measles sero-epidemiology
From 1973 to 1977, antibody positive rate of measles in-
creased from 73.3% to 95.8%, while incidence decreased
from 248.7/100,000 to 42.2/100,000. Antibody positive
rate of children 1–4 years was relative low, 63.8%-87.5%,
when the first dose of MV was administrated at 6 months.
Antibody positive rate of children 5–9 years was increased
to 84.3%-97.4%, when the second and third dose of MV
was administrated at 4 and 8 years old. From 1978 to
1996, antibody positive rate increased from the lowest
75.7% to higher 93.6%, while incidence declined from
highest 146.0/100,000 in 1978 to lowest 0.3/100,000 in
1995. Age-specific antibody positive rate of 1–4 years was
increased greatly from 68.0% to 97.9% while the first and
second dose of MV was administrated at 8 months and
1.5 years old. Antibody positive rate increased from 70.6%
to 98.0% for 5–14 years old , while students in Grade 1
and 7 was administrated MV from 1982. From 1997 to
2004, measles antibody positive rate fall to 93.4% and
73.4%, while incidence appeared slight rebound. During
this period, age-specific antibody positive rate of 1–14
years was between 85.7% and 100%, except 68.6%-80.0%
in 2003. Range of antibody positive rate in infants <1 years
was 30.0%-61.2% (Figure 7).
Discussion
Based on the trend analysis data from previous 60 years
in this study, the measures of prevention and control





Figure 4 Spatiotemporal distribution of measles incidence in different stages, 1982–2011.
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http://www.biomedcentral.com/1471-2458/13/986the epidemic dynamics of measles. Consistent with ob-
servations from other countries, epidemic cycles of mea-
sles occurred every 2–3 years in Beijing before measles
vaccination, when measles virus was in a natural infectious
state. Virtually everyone experienced measles illness dur-
ing the childhood [16]. 91% of individuals were infected
by the age of 1–4 years. After implementation of measles
vaccination, especially program immunization with two
doses at age of 8 months and 1.5 years in 1978, measles
incidence drop dramatically [17,18], but resurgencesoccurred in 1982 and again in 1986. These resurgences
may result from low effectiveness of liquid MV from Jing55
strains [19] and an accumulation of susceptible to a
critical threshold level. This highlighted that situation
of lower immunogenicity and administration of two
doses was inadequate for the interruption of measles
transmission. Jing55 MV strains were replaced by Hu191
strains, which had good immunogenicity and long-term
persistence [20] and the third dose was introduced since
















Figure 5 Seasonality of measles in 1985–2011. The reported cases number by month before 1985 was not recorded in the
historical documents.
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munogenicity. Increasing vaccination coverage led to de-
clining incidence of measles to historical lowest level in
1995 and longer inter-epidemic periods of 3–4 years. The
incidence of measles appeared rise from 2005 due to en-
hancement of measles surveillance susceptibility through
directly reporting suspected measles cases by network
[21]. The 2010 national MV SIAs targeting children aged
8 months to 14 years was successful in largely interrupting
measles virus transmission, resulting in almost historical
lowest level of measles incidence in 2011.
With the increasing vaccination coverage in Beijing,
the age distribution of cases shifted from younger chil-















Figure 6 Measles Incidence and immunization coverage rate in Beijinadults of 15–30 years; The upward shift in the age of
measles cases to older age groups with increasing MV
coverage was well documented in other settings [22-25].
Toward the end of endemic measles virus transmission
in the Americas, outbreaks in some regions included
cases among older children and young adults [26,27]. In
Beijing, young adults, especially migrant workers from
other province living in the poor and crowd environment,
clearly played a large role in the initial spread of measles
epidemic. China could be divided into 3 groups: eastern,
central and western provinces or regions, according to
economic and social development. Migrants leaved their
hometown in western and central provinces including to
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Figure 7 Measles Incidence and antibody positive rate in Beijing, 1973–2007.
Li et al. BMC Public Health 2013, 13:986 Page 8 of 11
http://www.biomedcentral.com/1471-2458/13/986and Anhui, et al. and swarmed to the eastern and more
developed provinces including Beijing, Shanghai, Guang-
dong, Zhejiang, et al. in recent two decades. The national
measles surveillance indicated that the average reported
measles incidence decreased more in the Western (from
131.2/100,000 to 105.8/100,000) than in the Central prov-
inces (from 57.6/100,000 to 55.5/100,000) from 1990–
1999 to 2000–2009. In contrast, incidence in the eastern
provinces increased from a lower level of 38.8/100,000 in
1990–1999 to 65.0/100,000 in 2000–2009. Persons in this
age group likely remained susceptible to measles because
most were born during the period of MV introduction
into the routine immunization program and scaling up ofcoverage [28]. These young adults born during 1970s-
1990s were more likely escaped from both natural mea-
sles infection and measles vaccination, when measles
incidence declined and vaccine coverage was not high
during initial period of measles vaccination, especially
in other province with lower development of immunization
service [29]. Many your adults and migrant population did
not have positive measles antibody. It was important
to immunize adults susceptible to measles in Beijing. Mea-
sles vaccination campaign targeted migrant workers aged
15–40 years was conducted each year since 2005 and had a
certain effect on control measles in migrant works in
Beijing. Proportion of farmers, workers and farmer workers
Li et al. BMC Public Health 2013, 13:986 Page 9 of 11
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ever, these populations had a strong mobility. Large-scale
immunization may not interrupt measles virus transmis-
sion. For infants, the age of infection decreased slightly and
the proportion of measles case increased gradually with
higher vaccination coverage from 1978 in Beijing. Infants
born to immune mothers received maternal antibodies
transferred during the perinatal period and remained
protected, on average, until approximately 4–6 months of
age [30]. However, transferred maternal antibodies that
were vaccine-induced rather than naturally acquired
following measles infection generally existed at lower
geometric mean titers in the mother and infant and
waned much earlier, leaving the infant unprotected as
early as 1 month of age [31,32]. In addition, the rela-
tively high incidence among infants and young adults
suggested that many young mothers may never have
been vaccinated or acquired natural immunity, leaving
their newborn children at increased risk from birth be-
cause they lacked protective maternal antibody against
measles. The outcome of Beijing and other Western Pa-
cific Region countries and areas will help determine
whether ensuring high population immunity among
adults is necessary to achieve measles elimination in
other regions.
Measles incidence has varied widely by district. From
1998 to 2011, the incidence was higher in Chaoyang,
Changping and Fengtai districts. Over 50% of cases were
reported from these three districts. The flow of migrant
workers from other provinces caused the spread of the
disease. These three districts are the suburb in Beijing,
in which population increase dramatically with develop-
ment of economics [33]. The density of the population
was higher compared with other districts [34]. Large
population size and high population density negatively
impact the progress of measles elimination [35]. Increas-
ing numbers of migrant workers could be major reason
for the higher incidence of measles.
To interrupt endemic transmission of measles virus,
mathematical models indicate that ≥93%–95% population
immunity is needed [36]. In the region of the Americas,
measles was declared eliminated in 2002 after the success-
ful implementation of a strategy that included achieving
and sustaining a very high coverage (≥95%) of children
[37]. Application of similar strategies in 7 southern African
countries led to similar results [38]. In Beijing, the coverage
of first dose MV increased steadily and reached to almost
100% from 1990. However, a gap remained between the
second dose coverage and the 95% goal in 2002–2004
while SARS happened in China. The fact that the resur-
gence of measles incidence was found in 2005, especially
for age of 1–6 years also indicated that routine coverage
was insufficient to interrupt measles transmission in this
age group. In addition, MV coverage rates in migrantchildren were only 76.6%-81.6% through investigation in
1998–2003, which significantly lower than that in local
children [39-41]. SIAs among migrant children under 7
years old was implemented since 2000 in Beijing. The
immunization management for migrant children after SIAs
was improved greatly. However, the migrant children who
lived in populous townships or had shorter residence time
were still the emphasis [42-44]. Strong commitment and
effort were urgently needed to maintain 95% of 2 doses
routine coverage and measure coverage accurately.
This study had some limitations. Firstly, the reported
MV coverage used in our analysis was likely higher than
the actual MV coverage in some areas [45-47]. Secondly,
it is acknowledged that due to the lack of the annual
population structure in the earlier period (1957–1996),
average incidence was calculated assuming the same
population denominators by age group in the same stage
(1957–1962, 1978, 1984, 1987-1996). Thirdly, convenience
sampling was used in sero-epidemiology surveys, and the
population selected may bias distribution of measles anti-
body level.
Conclusions
This study showed the various effects of different strat-
egies on the incidence of measles in Beijing, China, which
would provide valuable information to commit local pub-
lic health policy making and could be applied at national
level. There remains a need to fully implement all compo-
nents of the measles control strategy, to consider fine-
tuning the strategies to sustain recent gains in measles
incidence reduction and to make further progress. The
emphasis is on implementing: (1) strategy to increase
measles vaccine coverage in migrant adults and migrant
children if transmission persists in these groups (2) rou-
tinely monitoring and validating reported vaccination
coverage; (3) further research needed to better understand
the changing measles epidemiology, including the role
that young infants and older age groups played in sustain-
ing measles virus transmission.
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